top of page
  • Writer's pictureLuke Mitchell

Connect Corporate Finance successfully facilitated Barrington James's acquisition of S3 Life Science Recruitment

CCF has successfully facilitated the transaction between Barrington James, a portfolio company of Orangewood Partners and S3 Life Science Recruitment for an undisclosed sum. The deal is Barrington's first acquisition, a significant milestone, which enhances the company's Human Capital services in Life Sciences with S3's expertise in Clinical and Pre-Clinical specialisations.

Established in 2002, S3 Science Recruitment connects talented individuals with leading organizations and institutions across the UK, Europe, and the United States. Their mission is to enable ground breaking discoveries and life-saving treatments today. Specializing in drug discovery, medical research, and the broader Life Sciences field, S3 support the UK's leadership in developing cures and treatments.

Dan Barrington (CEO), Barrington James

"We are thrilled to acquire S3 and expand our Human Capital services in Life Sciences. This acquisition enhances our offerings across Board and Executive partnerships, Permanent Recruitment, Contract Recruitment, Staffing, OSP, and FSP. S3's expertise in Clinical and Pre-Clinical specializations, both on a temporary and permanent basis, will perfectly complement Barrington James' comprehensive Life Science services, from Clinical to Post-Marketing, A.I., and beyond. We are excited to collaborate with Alex Barrie, and his team, and we look forward to significantly growing S3 in the coming years."

Luke Mitchell (Director, Head of Deal Origination), Connect Corporate Finance

"We are delighted to have supported Dan, Barrington James and Orangewood with this transaction - enhancing Barrington's offering with additional expertise in Clinical and Pre-Clinical specialisations."



bottom of page